Skip to main content

Advertisement

Table 1 Animal Information and SD 0 treatment dosages (Groups 1–5)

From: Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis

Treatment group Animal identification Sex Body weight (lb)     
Ivermectin/Pyrantel     Tablet administered Dose
(Group 1)     Ivermectin (μg) Pyrantel (mg) Ivermectin (μg/kg) Pyrantel (mg/kg)
  IDF-2 M 25.2 136 114 11.9 10.0
  UHH-2 M 23.3 68 57 6.4 5.4
  VTH-2 M 22.5 68 57 6.6 5.6
  IOF-2 M 21.5 68 57 7.0 5.8
  BFG-2 F 20.9 68 57 7.2 6.0
  PXC-2 F 20.8 68 57 7.2 6.0
  VVH-2 M 19.4 68 57 7.7 6.5
  GSC-2 F 19.3 68 57 7.8 6.5
Milbemycin/Spinosad     Tablet administered Dose
(Group 2)     Milbemycin (mg) Spinosad (mg) Milbemycin (mg/kg) Spinosad (mg/kg)
  FCG-2 F 24.0 9.3 560 0.9 51.3
  IUE-2 F 23.0 9.3 560 0.9 53.6
  UDH-2 M 22.9 9.3 560 0.9 53.8
  VCG-2 F 21.5 9.3 560 1.0 57.3
  TPH-2 M 21.2 9.3 560 1.0 58.1
  XBH-2 M 20.5 9.3 560 1.0 60.1
  EZG-2 F 19.3 4.5 270 0.5 30.8
  KUH-2 M 17.6 4.5 270 0.6 33.8
Selamectin     Applicator tube Dose
(Group 3)     Selamectin (mg) Selamectin (mg/kg)
  OFF-2 M 24.7 120 10.7
  VUH-2 M 23.2 120 11.4
  EYE-2 F 21.5 120 12.3
  UKG-2 F 21.3 120 12.4
  AVG-2 F 20.9 120 12.6
  GPG-2 F 20.4 120 12.9
  GDE-2 F 18.6 60 7.1
  ZXG-2 F 19.9 60 6.6
Moxidectin/ Imidacloprid     Applicator tube Dose
(Group 4)     Moxidectin (mg) Imidacloprid (mg) Moxidectin (mg/kg) Imidaclopridd (mg/kg)
  DIH-2 M 23.9 62.5 250 5.8 23.0
  UYH-2 M 23.3 62.5 250 5.9 23.6
  CGH-2 M 22.2 62.5 250 6.2 24.8
  FKC-2 F 21.5 62.5 250 6.4 25.6
  FJC-2 F 20.8 62.5 250 6.6 26.4
  VZG-2 F 20.6 62.5 250 6.7 26.7
  LAG-2 F 19.5 25.0 100 2.8 11.3
  THH-2 M 18.8 25.0 100 2.9 11.7
Non-treated control      
(Group 5) UTH-2 M 24.6 NA NA NA NA
  GKC-2 F 23.3 NA NA NA NA
  TWH-2 M 21.8 NA NA NA NA
  EDG-2 F 21.2 NA NA NA NA
  RAF-2 M 21.0 NA NA NA NA
  CRC-2 F 20.3 NA NA NA NA
  TJH-2 M 20.2 NA NA NA NA
  IXG-2 F 18.3 NA NA NA NA